Rare diseases
Investigational molecules
Locations
Back to Germany262 clinical trials in Bochum, Germany across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of V940 and Pembrolizumab for Patients with Resected Stage II, IIIA, IIIB Non-Small Cell Lung Cancer
GermanyStudy on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis
GermanyStudy of KYV-101 Therapy for Patients with Refractory Generalized Myasthenia Gravis
GermanyStudy of Meclofenamate Sodium and Temozolomide for Patients with Progressive MGMT-Methylated Glioblastoma
GermanyStudy on the Effects of Immunoglobulin A, G, and M in Patients with Peritonitis and Sepsis After Infection Control
GermanyStudy on the Effects of Iptacopan in Patients with Generalized Myasthenia Gravis
GermanyStudy on Bortezomib for Patients with Severe Autoimmune Encephalitis
GermanyStudy on Scabies Treatment Comparing 10% Permethrin Cream to 5% Permethrin Cream for Patients with Scabies
GermanyStudy on the Effectiveness and Safety of Riliprubart Compared to Intravenous Immunoglobulin in Patients with Chronic Inflammatory Demyelinating Polyneuropathy
GermanyStudy on the Effects of Sirolimus and Drug Combination for Children Under 4 Months with Tuberous Sclerosis Complex
GermanyStudy on Early Sedation with Dexmedetomidine vs. Placebo for Older Critically Ill Patients on Ventilators
GermanyStudy on Venetoclax and Drug Combination for Adults with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with Excess Blasts-2
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on skin conditions, including studies for cutaneous lupus erythematosus, hidradenitis suppurativa, and plaque psoriasis. Novel therapeutic approaches are being evaluated to improve treatment outcomes for patients with chronic skin disorders.
Multiple studies are investigating new medications for moderate to severe cases of these conditions.
Innovative research in cancer treatment, particularly focusing on colorectal cancer, pancreatic cancer, gastric cancer, and non-small cell lung cancer. These trials are evaluating targeted therapies and combination treatments.
New therapeutic approaches combining immunotherapy with targeted treatments are being studied.
Studies focusing on heart failure prevention and chronic kidney disease management. Research includes innovative combination therapies and preventive approaches for high-risk patients.
Trials are evaluating new treatment combinations to improve patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
